Ann Fiegen Durbin
About Ann Fiegen Durbin
Ann Fiegen Durbin serves as the Associate Director of Assay Development at Abeona Therapeutics in Cleveland, Ohio. She has expertise in nucleic acids, immunology, virology, biochemistry, and assay development, complemented by strong leadership and communication skills.
Work at Abeona Therapeutics
Ann Fiegen Durbin serves as the Associate Director of Assay Development at Abeona Therapeutics, a position she has held since 2021. In this role, she contributes to the development of assays that are critical for therapeutic advancements. Her work is based in Cleveland, Ohio, where she utilizes her expertise to enhance the company's research capabilities.
Education and Expertise
Ann Fiegen Durbin holds a Doctor of Philosophy (Ph.D.) from Harvard University, which she completed from 2010 to 2016. She also earned a Bachelor's Degree from Xavier University, studying from 2006 to 2010. Her educational background supports her expertise in nucleic acids, immunology, virology, biochemistry, and assay development.
Background
Ann Fiegen Durbin completed her high school education at Roseville Area High School from 2002 to 2006. This foundational education preceded her advanced studies at Xavier University and Harvard University, shaping her academic and professional journey.
Leadership Skills
In her role at Abeona Therapeutics, Ann Fiegen Durbin demonstrates strong leadership skills within a matrix organization. Her ability to communicate effectively and organize complex projects contributes to her success in managing assay development initiatives.